| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026510816 |
| P356 | DOI | 10.1023/A:1018854906444 |
| P698 | PubMed publication ID | 9539647 |
| P2093 | author name string | M. Y. Sheikh | |
| R. A. Wright | |||
| J. B. Burruss | |||
| P2860 | cites work | Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources | Q29620774 |
| Effective control of patients with porphyria cutanea tarda by measuring plasma uroporphyrin | Q41148835 | ||
| The treatment of chronic viral hepatitis | Q41332870 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells | Q42198736 | ||
| Predictors of response to interferon therapy | Q42981053 | ||
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association | Q42982870 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Porphyria cutanea tarda and antibodies to hepatitis C virus. | Q43038650 | ||
| HCV infection in porphyria cutanea tarda | Q43038848 | ||
| Genotypic analysis of hepatitis C virus in American patients | Q43041871 | ||
| Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda | Q43815439 | ||
| Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment | Q44203363 | ||
| Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda | Q44872150 | ||
| Is hepatitis C virus infection a trigger of porphyria cutanea tarda? | Q45787026 | ||
| Interferon Preparations as Modifiers of Immune Responses | Q54017128 | ||
| Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration | Q71650797 | ||
| Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda | Q71698209 | ||
| Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease | Q71706694 | ||
| Response to interferon alpha therapy is influenced by the iron content of the liver | Q72022186 | ||
| Phlebotomy treatment of porphyria cutanea tarda | Q72065585 | ||
| [Porphyria cutanea tarda and chronic hepatitis C. Course after interferon therapy] | Q72237791 | ||
| Porphyria cutanea tarda remission | Q72685593 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | porphyria cutanea tarda | Q1479497 |
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 529-533 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C | |
| P478 | volume | 43 |
| Q57005545 | Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP |
| Q38153429 | Cutaneous porphyrias part II: treatment strategies |
| Q45743545 | Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces |
| Q56001841 | HEPATITIS C |
| Q38933599 | Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era. |
| Q35891695 | Hepatitis C virus and lichen planus |
| Q43939599 | Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C. |
| Q24647490 | Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C |
| Q44142634 | Porphyria cutanea tarda as rare cutaneous manifestation of hepatic metastases treated with interferon |
| Q35217843 | Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. |
| Q34743412 | The cutaneous manifestations of viral hepatitis |
| Q33952683 | The management of porphyria cutanea tarda |
| Q36082048 | Therapy of porphyria cutanea tarda |
| Q81573509 | [Cutaneous side effects of alpha interferon] |
Search more.